LRRK2 and Parkinson disease: These data provide strong evidence for LRRK2-mediated cohesion deficits in a subset of idiopathic PD patients and support the future inclusion of this readout as a blood-based biomarker for patient enrichment in clinical trials with LRRK2-related therapeutics.